Phase 1 trial of COVID-19 antibody drug begins

Phase 1 trial of COVID-19 antibody drug begins: US Pharma company Eli Lilly has started dosing participants in the Phase I clinical trial of antibody therapy to treat coronavirus. This is said to be the world’s first study to assess an antibody treatment for the disease.

Comments

Popular posts from this blog

Eurotech has carved its niche to address Networking and Communications requirements.

CLOUD COMPUTING : Nitin Hiranandani, Director, HP India

DCIM gaining momentum with growth of data centers